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Pengenalan :Terdapat pertindihan ciri-ciri yang sama bagi ketumbuhan tisu otot dan 
sokongan tulang melalui rutin imbasan magnetic (MRI).  
 
Objektif : Tujuan kajian ini adalah untuk membezakan ketumbuhan tisu otot and 
sokongan tulang yang merbahaya dan tidak merbahaya menggunakan nilai ADC dan 
untuk menentukan ketepatan ADC dengan keputusan kajian histopatologi tisu 
ketumbuhan tersebut.  
 
Metodologi: Kajian terhadap pesakit yang disyaki mempunyai ketumbuhan tisu otot, 
dirujuk untuk MRI dan memenuhi kriteria untuk terlibat dalam kajian ini. DWI dan peta 
ADC dikaji untuk mendapatkan bacaan nilai ADC. Kaitan antara nilai ADC dan jenis 
ketumbuhan telah dianalisa dengan ujian statistik. Nilai p kurang daripada 0.05 dikira 
sebagai signifikan.  
 
Keputusan: Sejumlah pesakit (n=40) dengan ketumbuhan tisu otot dan sokongan telah 
menjalankan pemeriksaan rutin MRI. Hanya 23 pesakit yang menepati kriteria untuk 
kajian ini dan mempunyai keputusan kajian tisu histopatologi terlibat dalam kajian ini. 
Sejumlah tiga belas pesakit (n=13) disahkan ketumbuhan merbahaya dan sepuluh 
pesakit (n=10) disahkan ketumbuhan tidak merbahaya melalui analisia tisu 
histopatologi. Pesakit dengan ketumbuhan merbahaya mempunyai nilai ADC yang lebih 
rendah daripada ketumbuhan tidak merbahaya. Perbezaan ini adalah ketara mengikut 
kajian statistik Mann-Whitney test (nilai p <0.001). Nilai ADC untuk ketumbuhan 
merbahaya adalah  1.04 x 10
-3








/sec (SD 0.51). Sensitiviti and spesifisiti nilai ADC untuk 
menentukan ketumbuhan merbahaya dan ketumbuhan tidak merbahaya berbanding 







Kesimpulan: Wujud perbezaan ketara antara nilai ADC ketumbuhan merbahaya dan 
tidak merbahaya. DWI juga mempunyai sensitiviti and specifisiti yang tinggi untuk 
menentukan ketumbuhan merbahaya dan tidak merbahaya berbanding dengan 
keputusan tisu analisis. DWI berpotensi membezakan ketumbuhan tisu otot dan 
sokongan tulang kepada merbahaya dan tidak merbahaya.  
 
Kata kunci: ketumbuhan tisu otot dan sokongan tulang, diffusion weighted imaging 















Introduction : Conventional magnetic resonance imaging (MRI) shows some 
overlapping features of malignant and benign musculoskeletal soft tissue tumour.  
 
Objectives : The purpose of this study is to characterise malignant and benign or 
tumour-like musculoskeletal soft tissue lesions using apparent diffusion coefficients 
(ADC) and to determine the accuracy of the ADC with histopathological examination 
(HPE) result.   
 
Methodology : Cross sectional study on patients referred for conventional magnetic 
resonance imaging (MRI) for suspected musculoskeletal soft tissue lesions and full-
filled the inclusion and exclusion criteria. Diffusion weighted imaging (DWI) and ADC 
maps were evaluated to obtain the mean ADC value. The relationship between the ADC 
value and type of tumours were analysed with statistical tests. The p value of less than 
0.05 was taken as statistically significant. 
 
Results : From all the forty (n=40) subjects who came for routine conventional MRI 
imaging for musculoskeletal lesions, only twenty-three (n=23) subjects full-filled the 
inclusion and exclusion criteria and histologically proven musculoskeletal soft tissue 
lesions were included in this study.  
Thirteen patients (n=13) had histologically proven malignant lesions and ten patients 
(n=10) had histologically proven benign or tumour-like lesions. Patients with malignant 
lesions demonstrated lower mean ADC value in comparison with the patient with 













/sec (SD 0.51). The 
sensitivity and specificity of mean ADC in predicting type of musculoskeletal soft 
tissue lesions comparing to histopathology examination report was 90.1% and 100% 






Conclusion: There was statistically significant difference of mean ADC value of 
malignant and benign or tumour-like lesions. DWI was also highly sensitive and 
specific as compared to tissue analysis to determine type of lesions. Thus, DWI has 
potential in differentiating malignant and benign soft tissue lesions. 
 
Keywords: musculoskeletal soft tissue tumour, diffusion weighted imaging (DWI), 




























Musculoskeletal soft tissue lesions are commonly encountered in our daily 
practice. Patient usually presents with palpable lump and bumps. The initial imaging is 
plain radiograph to look for osseous involvement, to locate the lesion and to look for 
nature of mineralization. Further imaging includes ultrasound for superficial lesion, and 
computed tomography (CT) scan and magnetic resonance imaging (MRI) for further 
characterisation of the lesion. Soft tissue lesions are categorised into tumour and tumor-
like lesion. Tumour or neoplastic lesion is a growing lesion which can further subdivide 
into benign; the harmless lesion and malignant; the dangerous and rapidly growing 
lesion. The tumour-like lesions are non-neoplastic and hence harmless. They include 
infection, inflammation, abscess or cyst.  
 
 The standard protocol MRI has an important role in characterisation of 
musculoskeletal soft tissue lesions depending on their signal intensity. It is the imaging 
modality for diagnosis, staging and follow-up of much musculoskeletal pathology. 
Some lesions demonstrate typical signal intensity on routine imaging such as for lipoma 
or cyst. However, there are also some overlapping features for benign and malignant 
lesions. The dermoid tumour for instance, a benign tumour, demonstrates imaging 
features of malignancy. The tumour-like lesion such as inflammatory or infection may 
appear as aggressive lesion on routine MRI imaging.  
 
Diffusion weighted imaging (DWI) is a recent addition to the conventional MR 
protocols, provides the functional information concerning the microscopic movements 




musculoskeletal soft tissue lesions. Apparent diffusion coefficient (ADC) values, which 
are obtained from the DWI images, represent cellularity activity and extracellular water 
content. Decreased ADC value reflects high cellularity and low extracellular water 
content as seen in malignant lesion whereas increased ADC value reflects breakdown of 
cell membrane integrity causing high extracellular water content. These features make 
DWI valuable tool for differentiating benign and malignant lesion. Thus, the diffusion 
weighted imaging (DWI) imaging might improve the diagnostic imaging accuracy. 
 
DWI is very commonly used in brain imaging. However, there are emergences 
and evolving usage of DWI in breast, liver and musculoskeletal imaging. A number of 
musculoskeletal disorders have been evaluated by using DWI, which includes vertebral 
fractures, bone marrow infection, bone marrow malignancy, bone and soft tissue 
tumours and post-treatment follow-up. The earlier studies showed overlapping ADC 
value of benign and malignant lesions. However, some recent studies showed 
significant difference between the ADC value of malignant and benign lesion. The 
ADC value of malignant lesion is lower as compared to benign lesion, reflecting 
restricted diffusion due to increased cellularity and limited extra-cellular space.  
 
Therefore, the aim of this study is to characterise the malignant and benign 
musculoskeletal soft tissue lesions using the DWI and ADC value. As the Hospital 
Universiti Sains Malaysia, Kubang Kerian, Kelantan is the Malaysia’s East Coast 
referral center for musculoskeletal lesions and reconstruction unit. The study was using 
3 Tesla MRI, and it is expected that DWI will be obtained with better signal-to-noise 
ratios (SNRs) hence, higher accuracy. Thus adding DWI to routine MRI protocols may 




1.2  Objectives  
  
1.2.1 General Objective:  
 
To differentiate malignant and benign musculoskeletal soft tissue lesions using 
diffusion weighted imaging (DWI).   
 
1.2.2 Specific Objectives: 
 
i. To compare mean apparent diffusion coefficient (ADC) between malignant and 
benign musculoskeletal soft tissue lesions.   
ii. To determine the accuracy of ADC in differentiating between malignant and 

















2.1 Musculoskeletal Soft Tissue Lesions  
 
Musculoskeletal soft tissues are tissues that connect, support and surround the 
skeletal system. They include from superficial to deeper structures; skin, adipose tissue, 
fascia, muscle, tendon, nerve, blood vessels and joints. They hold our bodies together 
with the skeletal system or bones and help to move. There are lesions arising from the 
soft tissues, which can be broadly classified as congenital and acquired. Congenital 
lesions develop before or at birth. It also can manifest during the first few months of 
life. Acquired conditions develop over a course of one’s life. It includes tumour or 
tumour-like lesions.  
 
Musculoskeletal soft tissue tumours or neoplasms are generally classified into 2 
main groups, which are benign and malignant or known as soft tissue sarcomas. They 
are derived from ectodermal and mesodermal layer and can occur at any age and site 
(Hochman, 2009; Zou et al., 2016). Benign tumours are generally harmless while 
malignant tumours are cancerous. Tumour-like lesions are non-neoplastic such as 
infection, abscess, inflammation or cysts (Bloem and Reidsma, 2012).  
 
2.2 Imaging of Musculoskeletal Soft Tissue Lesions  
 
The initial approach starts with clinical history, physical examination and 
location of the lesion. It is further characterised by imaging features such as 
mineralisation on plain radiographs, the nature of superficial lesion on ultrasound and 
signal intensity and enhancement pattern on CT scan and magnetic resonance imaging 




A study published by Gruber et al., (2017) showed that the most predictive 
features of malignant potential of unknown mass were heterogeneity on ultrasound, CT 
and MRI, lesion roundness, restricted diffusion, presence of cystic or necrotic 
intralesional areas, higher patient age, surrounding extensive oedema and intralesional 
Doppler hypervascularity (Gruber et al., 2017).  
 
Plain radiographs are cheap and readily available. Two standard views, frontal 
and lateral projections are required on imaging to locate the lesion. They also provide 
the information regarding mineralisation, underlying skeletal deformity or co-existing 
osseous involvement such as periosteal reaction or bone remodeling. However, plain 
radiographs are suboptimal to assess the small lesion and to detect subtle radiological 
features such as obliteration of fascia planes (Mark J. Kransdorf, 2000). CT is a useful 
adjunct in lesion that radiograph inadequately depict or characterise the lesions. As 
compared to plain radiographs, CT is beneficial for lesion in deeper structures such as 
in the pelvis. 
 
MRI is the mainstay of diagnosis, staging and follow-up of much 
musculoskeletal lesion. Compared to CT scan, MRI provides superior soft-tissue 
contrast, allows multiplanar image acquisition, obviates iodinated contrast agents and 
ionising radiation, and is devoid of streak artefacts commonly encountered with CT 
(Khoo et al., 2011). However, not all the medical centers are equipped with MRI.  MRI 
scanners are more expensive than CT scans. The imaging duration is longer thus 
susceptible to motion artefacts. MRI scanning is also not safe for patients with MRI 
non-compatible metal implants and foreign bodies, which can induce local heat and 




serious injury to patients and staff, and this requires special MRI compatible equipment 
and stringent adherence to safety protocols. MRI is a preferred modality for evaluating 
soft tissue tumour, to assess the origin, morphology and signal intensity, extension and 
the anatomical relationship with the neurovascular bundle and joints (Khoo et al., 
2011). MRI also beneficial at determining cystic versus solid components of the lesion 
and for characterising common tumour subtypes such as lipoma, vascular malformation 
and peripheral nerve sheath tumour (Fisher et al., 2016). 
 
A systemic imaging approach of soft tissue tumour and tumour-like lesions 
remains problematic due to overlapping and indeterminate characteristic of the lesions 
except for the simple lipoma and cyst that have unique signal intensity on conventional 
protocol (Song et al., 2017).  However, there are advances and emergences of imaging 
to improve the characterisation of the lesion. 
 
In view of overlapping imaging features of the soft tissue lesions, they are recent 
emergences of functional and metabolic imaging, namely the MR diffusion, MR 
perfusion or dynamic perfusion enhancement, MR spectroscopy and in-phase/opposed-
phase MRI (Drapé, 2013; Fisher et al., 2016; Laura M Fayad, 2012; Mark J. Kransdorf, 
2000). For the MR perfusion or dynamic perfusion enhancement, the main contributions 
for identification of viable tissue are depending on the types of MRI enhancement time 
versus intensity curves after the gadolinium injection. There are 5 types of curves which 
are type 1: no enhancement such as in lipoma or hematoma, type 2: faint and gradual 
enhancement as in benign tumours, type 3: rapid early enhancement followed by 
plateau as in benign vascular tumour, desmoid tumour or abscess, type 4: rapid early 




enhancement followed by slow gradual enhancement as in tumours post radiotherapy of 
chemotherapy. These techniques are widely used in monitoring response post 
chemotherapy or to detect residual or recurrent tumour (Drapé, 2013).  
 
For in-phase and opposed-phase imaging, it relies on the lipid/water ratio in a 
given tissue voxel particularly in bone marrow which consist of equally high water and 
fat contents. The simultaneous existence of water and fat in normal marrow results in 
signal suppression on opposed-phase images. However, in bone marrow infiltration that 
replaces the fat component, there is loss of signal suppression on opposed-phase 
images. Thus, it can differentiate pathological fracture from the acute mechanical 
fracture (Drapé, 2013). For in-phase and opposed-phased imaging or known as 
chemical shift imaging, it is widely used for liver, adrenal glands and bone tumours. 
However, little study was performed in imaging of soft tissue tumour possibly due to 
heterogeneity of fat and water content of the lesion. MR spectroscopy is also widely 
used for brain imaging. The lesions are characterized based on their metabolic 
constituents such as choline, which is found in cell membrane. An increased in choline 
level, indicated increased cell membrane turnover, which is indirect marker for 
malignancy. Apart from that, MR spectroscopy has been used in bone and soft tissue 
tumours, breast cancer, prostate cancer and cervical cancer (Drapé, 2013). 
 
2.3 Diffusion Weighted Imaging: Concept  
 
Diffusion weighted imaging (DWI) or MR diffusion serves the qualitative and 
quantitative characterisation of lesions by means of signal intensity on diffusion 




integrity of cell membrane. The basic concept of DWI is measuring the random 
movement of water molecules in vivo such as in the extracellular, intracellular and 
transcellular compartments. For highly cellular tissues, there is smaller extracellular 
compartment thus the water restriction is greater. This is applied in the malignant 
tumour. Restriction of water molecule is inversely proportionate to tissue cellularity. 
For benign lesion, the extracellular compartment is still adequate in view of lesser 
degree of cellularity, thus the water movement is less restricted (Bhojwani et al., 2015; 
Drapé, 2013).    
 
2.4 Diffusion Weighted Imaging: Technique  
  
 There are five main types of DWI sequences: (1) spin- echo DWI: the simple 
sequence with relatively high signal-to-noise ratio (SNR) but a long acquisition time; 
(2) single-shot echo planar imaging (SS-EPI): quicker acquisition times while 
maintaining relatively high SNR; but vulnerable to susceptibility artefacts, particularly 
at tissue interfaces; (3) Multi- shot echo planar imaging (MS-EPI): EPI sequence that 
divides the echo train into shorter parts, provides higher spatial resolution and is less 
susceptible to artefacts or distortions; however, it has a longer acquisition time; (4) 
single-shot fast spin-echo (SS-FSE): this sequence has similar speed and spatial 
resolutions to echo planar sequences, and are less sensitive to susceptibility artefacts; 
(5) steady-state free precision imaging (SS-FPI): a gradient-echo MRI pulse sequence 
with fat saturation. The most commonly used sequence is single shot EPI as it is simple 
and has short acquisition time and thus eliminate risk of motion artefacts (Drapé, 2013; 





 DWI used the diffusion gradients to filter water signal in conventional T2-
weighted images. Thus it improves the detection of water molecule diffusion and 
mobility and gives the greatest ADC value. To improve the accuracy of interpretation 
the diffusion, at least 2 different b values are generally used (0 and 600, or 0 and 1000 
s/mm2). The b-value reflects the diffusion force. Cystic tumours exhibit greater signal 
attenuation on high b-value images.  The higher diffusion force, the less restricted of 
water molecule movement. Whereas for solid masses and cellular tumours with 
restricted diffusion, they continue to generate a high-intensity signal independent on the 
diffusion force (Drapé, 2013). The different b-values reflect the qualitative 
characteristic of the lesion rather than quantitative characteristic, the ADC value. Many 
studies are using b value of ranging 0 until 800 s/mm
2
.   
 
2.5 Diffusion Weighted Imaging: Applications 
 
MRI diffusion is widely used in neuro-imaging particularly in cerebral 
pathology such as stroke and tumour.  However, its usage is expanding involving 
imaging of the breast, liver and musculoskeletal system (Vinit Baliyan, 2016). MR 
diffusion is easily available sequence in addition to the conventional routine MRI 
sequences for imaging of musculoskeletal soft tissue. A number of musculoskeletal 
disorders have been evaluated by DWI and hence the ADC including vertebral fractures 
(Bhojwani et al., 2015; Dallaudiere et al., 2015; Geneidi et al., 2016; Khoo et al., 2011; 
Yao and Troupis, 2016), bone marrow infection and malignancy (Subhawong et al., 
2014), primary bone lesions (Dallaudiere et al., 2015; Geneidi et al., 2016; Hayashida et 
al., 2006a; Khoo et al., 2011; Kotb et al., 2014; Oh et al., 2017; Pekcevik et al., 2013; 




2015; Einarsdottir et al., 2004; Jeon et al., 2016; Khoo et al., 2011; Subhawong et al., 
2014; van Rijswijk et al., 2002a) and post-treatment follow-up to monitor for residual 
or recurrent disease, due to its ability to discriminate necrosis from viable tumours 
(Bhojwani et al., 2015; Dallaudiere et al., 2015; Einarsdottir et al., 2004; Hayashida et 
al., 2006b; Khoo et al., 2011; Yao and Troupis, 2016). Additionally, the lesions with 
decreasing ADC values can suggest malignant transformation and increasing ADC 
values post chemotherapy can suggest reduction in tumour size (Dudeck et al., 2008).  
 
A number of studies have been performed to characterise benign and malignant 
bone tumours There is significant difference of ADC value between benign and 
malignant bone tumours with lower ADC value in malignant tumour as compared to 
benign tumours (Ahlawat et al., 2015; Geneidi et al., 2016; Kotb et al., 2014; Neubauer 
et al., 2012; Oh et al., 2017; Pekcevik et al., 2013). The lesions were confirmed by HPE 
and clinical confirmation. They defined clinical confirmation by means of no 
underlying malignancy, no change in tumour size and extension; and no clinical 
evidence of disease progression in 6 months after the initial MRI (Oh et al., 2017). DWI 
is non-invasive method to evaluate tumour histological content. The tissue 
histopathological analysis is invasive method and yet being the gold standard for the 
final diagnosis (Fisher et al., 2016). There was some overlap in ADC values between 
benign and malignant bone tumours. The mean minimum ADC values of benign and 
malignant of chondroid tumours were high. Giant cell tumor, non-ossifying fibroma and 
fibrous dysplasia showed lower ADC values (Pekcevik et al., 2013). The other study 
reported overlapping in the ADC values of chondrosarcomas, solitary bone cyst, and 





There are also several studies to characterise benign and malignant soft tissue 
tumour using the DWI. The initial studies showed overlapping ADC value (Einarsdottir 
et al., 2004; van Rijswijk et al., 2002b). However, recent studies showed significant 
difference between the ADC value of benign and malignant soft tissue tumour. The 
patients diagnosed with malignant soft-tissue tumours have low ADC values of DWI 
compared to those with benign soft-tissue tumors (Jeon et al., 2016; Neubauer et al., 
2012; Song et al., 2017; Zou et al., 2016). A study by Song et al., (2017) also reported 
that ADC values for myxoid tumours were significantly higher than those of non-
myxoid tumour. However, the myxoid component can be characterised well using 
conventional MRI due to their distinguishing features such as fluid-like signal intensity 
on T2-weighted imaging and variable degree of enhancement of the myxoid component 
(Song et al., 2017). 
 
 Another study by Pekcevik et al. (2015) showed the mean ADC values were 
different between benign and malignant soft tissue tumors (p = 0.031). The mean ADC 









/ s respectively. Benign cystic tumours had significantly higher ADC values 
than benign solid or mixed tumours and malignant solid or mixed tumours (p values 
were  0.001 and 0.003, respectively). Malignant solid or mixed tumours had lower ADC 
values than benign solid or mixed tumours (p = 0.02) (Pekcevik et al., 2015). 
  
 Another study by Subhawong et al. (2013) showed higher mean ADC values in 




/ s, p < 0.005) 
(Subhawong et al., 2013).  However, the findings of solid and cystic masses are easily 
